Amn Healthcare Inc (AMN) valuation
Amn Healthcare P/E ratio history
Amn Healthcare trades at 17.5 times its earnings over the last twelve months and 22.3 times the earnings analysts expect over the next twelve. At its last 8 fiscal year ends its P/E ranged from 10.4 (year to Dec 2022) to 46.1 (year to Dec 2020), with a median of 18.1.
| Fiscal year ended | Price | EPS | P/E | Forward P/E |
|---|---|---|---|---|
| Dec 31, 2025 | $15.76 | -$2.48 | n/m | 17.2 |
| Dec 31, 2024 | $23.92 | -$3.85 | n/m | 12.1 |
| Dec 31, 2023 | $74.88 | $5.36 | 14.0 | — |
| Dec 31, 2022 | $102.82 | $9.90 | 10.4 | 11.2 |
| Dec 31, 2021 | $122.33 | $6.81 | 18.0 | — |
| Dec 31, 2020 | $68.25 | $1.48 | 46.1 | — |
| Dec 31, 2019 | $62.31 | $2.39 | 26.1 | — |
| Dec 31, 2018 | $56.66 | $2.92 | 19.4 | — |
| Dec 31, 2017 | $49.25 | $2.69 | 18.3 | — |
| Dec 31, 2016 | $38.45 | $2.15 | 17.9 | — |
n/m: not meaningful (a loss, or earnings close to zero). The daily P/E line is a chart indicator in the app.
Amn Healthcare valuation against its peers
| Company | Market value | P/E | Forward P/E | Price / sales |
|---|---|---|---|---|
| Amn HealthcareAMN | $1.83B | 17.5 | 22.3 | 0.5 |
| Agios PharmaceuticalsAGIO | $1.82B | — | — | 18.5 |
| Xeris BiopharmaXERS | $1.85B | — | 202.3 | 5.5 |
| LeMaitre VascularLMAT | $1.85B | 28.3 | 26.7 | 7.1 |
| Sellas Life Sciences GroupSLS | $1.80B | — | — | — |
| AzentaAZTA | $1.80B | — | 82.4 | 2.9 |
| Zenas BiopharmaZBIO | $1.79B | — | — | — |
| Vir BiotechnologyVIR | $1.91B | — | — | 6.3 |
| Maze TherapeuticsMAZE | $1.74B | — | — | 87.1 |
| Peer median | 28.3 | 82.4 | 6.7 |
Reading these multiples
The P/E divides the share price by earnings per share over the last twelve months; the forward P/E divides it by the earnings analysts expect over the next twelve. Price to sales compares the company's market value with its revenue over the last twelve months. A multiple reads differently from one industry to the next, so the peer group above is the fairer comparison.
See also: AMN financials · AMN returns
No forecast, no recommendation. This page describes Amn Healthcare Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.